Pharmaceutical Companies Explore New Drugs for Sleep Reduction

Pharmaceutical companies are reportedly investing in a new class of drugs, currently used for rare neurological disorders, to determine if they could allow individuals to function without the need for sleep. This represents a significant potential development in neuroscience.